Clinical trials: Monotherapy With Xalatan From 1 to 18 Months
Glaucoma, Monotherapy With Xalatan From 1 to 18 Months
Assessing Ocular Surface Changes After Changing Glaucoma Medications
Hypothesis: Changing to Travatan Z therapy increases the tear film break up time of subjects on Xalatan therapy presenting with ocular surface disease.
- Conditions
- Glaucoma, Monotherapy With Xalatan From 1 to 18 Months, Ocular Surface Disease
- Trial name
- NCT00554411
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- University of Colorado, Denver